Tayahop, Baby Boy .

HRN: 21-32-90  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/12/2022
AMPICILLIN 250MG (VIAL)
05/12/2022
05/18/2022
IV
130mg
Q12hrs
PSNB
Waiting Final Action 
05/12/2022
GENTAMICIN 40MG/ML, 2ML (AMP)
05/12/2022
05/18/2022
IV
13mg
OD
PSNB
Waiting Final Action 
08/25/2023
CEFUROXIME 750MG (VIAL)
08/25/2023
09/01/2023
IV
280mg
Q8
PCAP C
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: